Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Microplate Instruments Simplify Performance, Maximize Results for ELISA Applications

Published: Monday, November 18, 2013
Last Updated: Monday, November 18, 2013
Bookmark and Share
The Thermo Scientific Multiskan FC (IVD model) and Wellwash (IVD model) microplate instruments now conform to the European In Vitro Diagnostic Directive 98/79/EC and are available throughout Europe.

Microplate photometer and microplate strip washer provide a simple, modular solution to maximize results for routine enzyme-linked immunosorbent assays (ELISA) applications in diagnostic, as well as quality control laboratories.

“Researchers working in ELISA applications need simplified solutions that will help maximize their efforts and results,” said Hanna Granö-Fabritius, business director, sample preparation & analysis, Thermo Fisher Scientific. “Our instruments are critically important for vitro diagnostics use and lab managers can be assured that these products are compliant with the IVD Directive requirements. Our instruments are designed to offer convenience and reliability in clinical diagnostics and quality control laboratories to improve ease of use and accelerate results.”

Designed with 30 years’ experience in microplate photometry, the Thermo Scientific Multiskan FC instrument is a reliable and robust filter-based microplate photometer, measuring absorbance in the wavelength range of 340 to 850 nm. The Thermo Scientific Wellwash instrument is an easy-to-use microplate strip washer offering convenience and versatility ideal for routine assay runs. Both the Thermo Scientific Multiskan FC microplate photometer and Thermo Scientific Wellwash microplate strip washer are compact, simple and easy-to-use, enhancing ELISA productivity and throughput.

Features include:

• Large color display with a logical and intuitive graphical user interface for easy use and operation

• Internal software available eight different languages (English, French, German, Spanish, Portuguese, Russian, Japanese and Chinese) for regional customization

• USB ports for transferring data and protocols


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Fisher Scientific and bioMérieux Renew Partnership
The companies have renewed their non-exclusive, long-term, royalty-bearing agreement for Procalcitonin testing.
Wednesday, October 03, 2012
Thermo Scientific Opens Molecular Biology Center of Excellence in Lithuania
New facility expands R&D and manufacturing capabilities in eastern Europe for molecular, protein and cellular biology products.
Friday, September 21, 2012
Scientific News
New Weapon in the Fight Against Blood Cancer
This strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Scientists Create CRISPR/Cas9 Knock-In Mutations in Human T Cells
In a project spearheaded by investigators at UC San Francisco, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Immune System 'On Switch' Breakthrough Could Lead to Targeted Drugs
A crucial 'on switch' that boosts the body's defenses against infections has been successfully identified in new scientific research.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Iron Regulators Join War on Pathogens
Iron regulatory proteins (IRPs) play an important role in the body’s immune system.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!